I graduated from Biochemistry by Universidad Autónoma de Madrid (UAM) in 2018, studying one semester at Boston University as a BU-UAM Science School scholar. As an undergrad, I performed wet and dry lab internships that applied omics technologies to detect rare mutations (Centro de Biologia Molecular Severo Ochoa, Spain) and to understand mouse limb development (Miguel Torres’ group at CNIC, Spain). During my Master’s and as a Fundación Margrit y Folke Pehrzon fellow, I left the wet lab to focus on the analysis of omics data with a systems biology perspective, first as a research intern at the clinical genetics laboratory (Karolinska Institutet, Sweden) and then at Erik Sonnhammer’s Systems Biology group (SciLifeLab, Sweden), where I used network modelling to quantify drug repurposing opportunities in over 100 complex diseases, including COVID-19. After my Master’s I joined Miguel Torres’ and Fatima Sanchez-Cabo groups at CNIC funded by a “la Caixa” INPhINIT doctoral fellowship. As a PhD Student, I modelled the gene regulatory networks controlling cardiomyocyte proliferation in mouse and axolotl for the discovery of new therapeutic targets to induce heart regeneration. My PhD project included a research stay in Elly Tanaka’s group at IMBA (Austria) and was part of the REANIMA Project funded by Horizon2020.

In January 2025, I joined Saez Lab as a postdoc to work on the integration of bulk and single-cell omics data to identify key molecular circuits and therapeutic interventions to fight cardiac disease.